featured
2020 Top Stories in Oncology: Early Local Therapy vs Systemic Therapy Alone for De Novo Stage IV Breast Cancer*
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Halsted WS. The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 1907;46(1):1-19.
- Urban JA. Primary surgical treatment of breast cancer. Semin Surg Oncol. 1988;4(4):234-243.
- DeSantis CE, Fedewa SA, Goding Sauer A, et al. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66(1):31-42.
- Khan SA, Zhao F, Solin LJ, et al. A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: a trial of the ECOG-ACRIN Research Group (E2108). J Clin Oncol. 2020;38(18_sppl):LBA2.
- Badwe R, Hawaldar R, Nair N, et al. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol. 2015;16(13):1380-1388.
- Anderson BO. Early local therapy vs systemic therapy alone for de novo stage IV breast cancer. PracticeUpdate website. June 5, 2020. Accessed December 6, 2020.
Disclosure statements are available on the authors' profiles: